| (INR) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 34.43B | — |
| Operating expense | — | — |
| Net income | 5.54B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, MANKIND.NS returned -8.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +8.5% |
| 1 year | -8.5% |
| All-time high | ₹2,880.40 (Dec 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₹1,000 in MANKIND.NS would be worth today ›No. Mankind Pharma Limited has not paid a dividend in the past 12 months.
Mankind Pharma Limited is part of the Healthcare sector.
Mankind Pharma Limited has a market cap of 980.66B INR, based on the latest quote.
Mankind Pharma Limited is expected to report earnings around Oct 29, 2026. That date is an estimate and has not been confirmed by the company.
